Atossa Therapeutics: Ascendiant Capital Markets raises target price to $25 from $24
ATOS•Ascendiant Capital Markets raised its target price for Atossa Therapeutics to $25 from $24.
ATOS•ATOS•ATOS•Ascendiant Capital Markets raised its target price for Atossa Therapeutics to $25 from $24.
